Cutaneous manifestations of Corynebacterium jeikeium sepsis

International Journal of Dermatology

Volumn 48, Issue 8, 2009, Pages 886-888

  Olson, Jonathan M ^a   Nguyen, Viet Q ^a,b   Yoo, Jane ^a   Kuechle, Melanie K ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CYTARABINE; DAUNORUBICIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CASE REPORT; CORYNEBACTERIUM; CORYNEBACTERIUM JEIKEIUM; ERYTHEMA; FEBRILE NEUTROPENIA; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; NONHUMAN; PAPULE; PETECHIA; RASH; SEPSIS; SKIN BIOPSY; SKIN EXAMINATION; SKIN INFLAMMATION; SKIN MANIFESTATION; SKIN NECROSIS;

CORYNEBACTERIUM INFECTIONS; DERMATITIS; ERYTHEMA; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RISK FACTORS; SEPSIS;

EID: 67949122063     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03984.x     Document Type: Article

References (16)

1. Hande KR, Witebsky FG, Brown MS, et al. Sepsis with a new species of Corynebacterium. Ann Intern Med 1976; 85: 423-426.
2. Riley PS, Hollis DG, Utter GB, et al. Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol 1979; 9: 418-424.
3. Kazmierczak AK, Szarapinska-Kwaszewska JK, Szewczyk EM. Opportunistic coryneform organisms - residents of human skin. Pol J Microbiol 2005; 54: 27-35.
4. Johnson AP, Warner M, Malnick H, et al. Activity of the oxazolidinones AZD2563 and linezolid against Corynebacterium jeikeium and other Corynebacterium spp. J Antimicrob Chemother 2003; 51: 745-747.
5. van der Lelie H, Leverstein-Van Hall M, Mertens M, et al. Corynebacterium CDC group JK (Corynebacterium jeikeium) sepsis in haematological patients: A report of three cases and a systematic literature review. Scand J Infect Dis 1995; 27: 581-584.
6. Wang CC, Mattson D, Wald A. Corynebacterium jeikeium bacteremia in bone marrow transplant patients with Hickman catheters. Bone Marrow Transplant 2001; 27: 445-449.
7. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29: 490-494.
8. Dan M, Somer I, Knobel B, et al. Cutaneous manifestations of infection with Corynebacterium group JK. Rev Infect Dis 1988; 10: 1204-1207.
9. Stamm WE, Tompkins LS, Wagner KF, et al. Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med 1979; 91: 167-173.
10. Mookadam F, Cikes M, Baddour LM, et al. Corynebacterium jeikeium endocarditis: A systematic overview spanning four decades. Eur J Clin Microbiol Infect Dis 2006; 25: 349-353.
11. Guarino MJ, Qazi R, Woll J, Rubins J. Septicemia, rash, and pulmonary infiltrates secondary to Corynebacterium group JK infection. Am J Med 1987; 82: 132-134.
12. Jerdan MS, Shapiro RS, Smith NB, et al. Cutaneous manifestations of Corynebacterium group JK sepsis. J Am Acad Dermatol 1987; 16 (Pt 2): 444-447.
13. Jucgla A, Sais G, Carratala J, et al. A papular eruption secondary to infection with Corynebacterium jeikeium, with histopathological features mimicking botryomycosis. Br J Dermatol 1995; 133: 801-804.
14. Pearson TA, Braine HG, Rathbun HK. Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment. J Am Med Assoc 1977; 238: 1737-1740.
15. Gill VJ, Manning C, Lamson M, et al. Antibiotic-resistant group JK bacteria in hospitals. J Clin Microbiol 1981; 13: 472-477.
16. Sanchez Hernandez J, Mora Peris B, Yague Guirao G, et al. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum. Int J Antimicrob Agents 2003; 22: 492-496.